Strong Order Momentum and Backlog Growth
Orders of $327 million, up 10% year-over-year, with backlog increasing approximately $32 million to $109 million, signaling strong demand momentum and healthy customer relationships.
Robotics (AMR) Business Acceleration
AMR sales of approximately $27 million in Q1 (9% of total net sales), representing 85% year-over-year robotics growth; cumulative shipments >11,500 robots; extended exclusivity with Brain Corp to 2029; launched X16 SWEEP and X2 ROVR; plan to introduce 10 new AMR products over 24 months and targeting $250 million in AMR revenue by 2028.
Revenue Growth and Product Mix Strength
Consolidated net sales of $297.9 million, up 2.7% year-over-year; equipment sales up 3.1% and service & other up 10.6%, reflecting momentum in commercial products and recurring autonomy subscription revenue.
Sequential Margin Recovery and Stabilization Progress
Gross margin improved sequentially each month with Q1 margin at 38.1% (a 350 basis point improvement vs. Q4 2025) and an enterprise gross margin exit rate of ~40% in March, indicating operational stabilization after ERP go-live.
Reaffirmed 2026 Guidance and Long-Term Targets
Management reaffirmed full-year 2026 guidance: net sales $1.24B–$1.28B (organic growth 3.0%–6.5%), adjusted EBITDA $175M–$190M (14.1%–14.8% margin), adjusted diluted EPS $4.70–$5.30; expects results weighted to second half of year.
Prudent Capital Allocation and Strong Liquidity
Deployed $60 million to repurchase ~950,000 shares (~5% of beginning-of-year shares) at an average price of $63; Board authorized additional 2.0 million share repurchase (total repurchase capacity ~2.56 million shares, ~15% of basic shares); ended quarter with $82.6 million cash and ~$289 million unused revolver capacity; net leverage 1.78x (within 1–2x target).